Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
January 10, 2021 14:00 ET
|
Emergent BioSolutions
Expects continued strong financial and operating momentum in 2021, forecasting total revenues of $2 billion at the midpoint and Adjusted EBITDA of $780 million at the midpoint, both increases...
Emergent BioSolutions to Participate in Investor Conferences
January 04, 2021 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Translate Bio to Participate in Upcoming Investor Conferences
September 29, 2020 16:05 ET
|
Translate Bio, Inc.
LEXINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
September 28, 2020 07:00 ET
|
Precision Biosciences
DURHAM, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
Translate Bio to Participate in Upcoming Investor Conferences
September 03, 2020 07:30 ET
|
Translate Bio, Inc.
LEXINGTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
September 02, 2020 16:01 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Emergent BioSolutions to Participate in Virtual Investor Conferences
August 18, 2020 06:31 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
TTM Technologies, Inc. Announces Upcoming Conference Participation
August 03, 2020 16:05 ET
|
TTM Technologies
SANTA ANA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (PCB) and radio frequency (“RF”) components manufacturer, today...
Emergent BioSolutions to Participate in Virtual Investor Conferences
June 16, 2020 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Emergent BioSolutions to Participate in Virtual Investor Conferences
May 12, 2020 06:00 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...